That superhero is a gene called TP53, and for decades scientists have known it as the “guardian of the genome.” In a healthy cell, TP53 acts like both a brake and an emergency stop button. When DNA ...

From a study that analyzed the therapeutic dilemma of treating acute leukemia (AL) during pregnancy and the delicate balance of improving maternal and fetal outcomes, investigators determined that ...

The Alliance for Clinical Trials in Oncology has launched a new clinical trial for adults who need first-line therapy for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The ...

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

New research into acute myeloid leukemia could change future treatment approaches.

It's unlikely that Savannah Guthrie's missing mom, Nancy, is still alive, according to a former special deputy U.S. marshal. Spencer went on to tell viewers that due to the grim statistic, you should ...

(Beyond Pesticides. February 24, 2026) Leukemia is the leading contributor to the clear rise in childhood cancer cases over the last few decades, and the general association of pesticide exposures ...

Screening dramatically increases the survival rate for breast cancer patients, according to new research. Women with stage IV breast cancer detected through screening have a 60% chance of still being ...

Women with stage IV breast cancer detected through screening have a 60% chance of survival 10 years after diagnosis. This is in comparison to a survival rate of under 20% of those with stage IV breast ...

Cancer survival hits 70% as early screening and immunotherapy advance—yet survivorship needs and Indigenous disparities demand urgent action. In the mid-1970s, a cancer diagnosis was essentially a ...

BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center is celebrating a new report with positive news about cancer survivorship rates. In the annual report from the American Cancer Society tracking ...

Post hoc data suggest Orca-T may boost survival and cut non-relapse mortality after allogeneic stem cell transplant in MDS and leukemias, pending phase 3 validation. A novel cellular therapy, Orca-T, ...